Skip to main content
evidena care

Basics

What are terpenes? What is known about terpenes in cannabis

Terpenes are aroma compounds of the cannabis plant. What they do in humans has hardly been studied. The entourage effect remains a hypothesis to this day.

Key points

  • Terpenes are volatile fragrance and aroma compounds that the cannabis plant produces in its resin together with the cannabinoids. They are also found in many other plants and foods.
  • The entourage effect holds that terpenes change the effect of THC and CBD. This is a hypothesis: several cell studies found no effect of terpenes at the cannabinoid receptors, but the results are not consistent.
  • There are hardly any controlled studies in humans. A small study with 20 healthy adults found indications that inhaled limonene dampened the anxiety triggered by THC.
  • No benefit of particular terpenes for treating symptoms can be derived from these data. Which preparation is prescribed is decided by your doctor.

Terpenes are volatile fragrance and aroma compounds. The cannabis plant produces them together with the cannabinoids in the glandular hairs of its flowers. They shape smell and taste, and many of them are also found in foods.1,3

What terpenes from cannabis do in humans has hardly been studied. The idea that they enhance or change the effect of THC and CBD is called the entourage effect. To this day it is a hypothesis: several laboratory studies found no effect of common terpenes at the cannabinoid receptors, another came to the opposite result, and there are only a few controlled studies in humans.4,5,7,9

What are terpenes?

Terpenes are a large group of chemical compounds that plants build from the same basic building blocks. Chemically, a distinction is made between monoterpenes and sesquiterpenes, among others. In the specialist literature, the terms terpenes and terpenoids are often used side by side.1,3

Many of these substances occur in the diet. In his review article, Russo describes them as flavour and fragrance compounds that are common in the human diet and have been classified by US authorities as generally safe for food.3 This classification concerns food, not inhalation or highly concentrated products.

Terpenes in cannabis: where they come from

Cannabis produces a resin in its glandular hairs (trichomes), which are found mainly on the female flowers. Terpenes and cannabinoids sit side by side in this resin. A study at the University of British Columbia identified, in one hemp variety, the enzymes that produce a large part of the terpenes in the resin. The main constituents included beta-myrcene, limonene, alpha-pinene, beta-caryophyllene and alpha-humulene.1

The resin contains hundreds of different terpenes and cannabinoids, many of which have not yet been reliably identified. The authors of a 2019 review note that knowledge about how they are formed and about the factors that influence their composition is still rudimentary. They also point to the inconsistent composition of different plant varieties.2

For treatment, this means: the terpene content of plant material varies. Magistral preparations with a single active substance such as dronabinol, by contrast, contain defined amounts of one cannabinoid. More on the forms in the article Dosage forms compared.

The entourage effect: a hypothesis

The entourage effect hypothesis holds that the many constituents of the plant act differently together than a single active substance. For terpenes, it became known mainly through a 2011 review article by Ethan Russo. Russo brought together evidence from laboratory and animal studies and suggested that terpenes could contribute to the effect of cannabis extracts, for example in pain, inflammation or anxiety.3

The wording is important here. Russo himself speaks of “potential” synergies and writes that a synergy between cannabinoids and terpenes would, “if proven”, make new therapies possible. The article is therefore a research proposal, not proof of efficacy. At the time of publication, Russo was working for a manufacturer of cannabis medicines.3

What laboratory and animal studies show

An obvious explanation would be that terpenes act directly at the cannabinoid receptors CB1 and CB2 or enhance the effect of THC there. This has been tested several times in the laboratory:

  • An Australian research group tested six common cannabis terpenes on cells with human CB1 and CB2 receptors. None activated the receptors, and none changed the effect of THC. The authors conclude that an entourage effect, if it exists, does not work via these receptors.4
  • A New Zealand research group reached a similar result using other methods. With the possible exception of a weak interaction of beta-caryophyllene with CB2, it found no direct effect of the terpenes tested at CB1 or CB2.5
  • At two other receptors that play a role in pain (TRPA1 and TRPV1), the terpenes tested also did not change the effect of THC and other cannabinoids.6

A research group from Arizona came to a different result in 2021. In its cell experiments, all terpenes tested activated the CB1 receptor, and in mice some terpenes triggered cannabinoid-like behavioural effects and enhanced the effect of a synthetic cannabinoid. The authors see this as conceptual support for the hypothesis.7 However, results from mice cannot be transferred directly to humans.

What has been shown in humans: very little

Controlled studies in humans are rare. One of the few examined 20 healthy adults who used cannabis occasionally. In the study, they were given vaporised THC, limonene, both together or placebo in several double-blind sessions.8

The results:

  • Limonene alone did not differ from placebo in the effects measured.8
  • In the combination with the highest amount of limonene, which only 12 of the 20 participants received, participants rated feelings such as “anxious/nervous” and “paranoid” lower than with THC alone.8
  • Limonene did not change other effects of THC, for example on concentration, reaction or pulse. The THC concentration in the blood also remained the same.8

The authors recommend further research, for example on oral forms. The study was small, involved healthy people rather than patients, and examined only one terpene.8

A critical review from 2026 summarises the situation: the evidence for a meaningful influence of terpenes on the effect of THC in humans is “exceptionally limited”. Many terpenes have not yet been studied in humans at all. Effects observed in animals have often not been confirmed in clinical studies.9

Terpenes and treatment with cannabis medicines

No benefit of particular terpenes for treating symptoms can be derived from these data. Studies showing that a particular terpene profile makes a difference in a condition are lacking.9,2

This is consistent with the FOPH’s general assessment: for most possible indications, especially with magistral preparations, there are not yet sufficient clinical data on efficacy.10 For terpenes, the data are even thinner than for THC and CBD.

If you have questions about a preparation, discuss them with your doctor. Terms such as cannabinoid or magistral preparation are explained in the glossary, and you will find more basics in the Basics section.

How it works at evidena

At evidena, the doctor decides after the assessment whether cannabis therapy can be considered and which preparation is prescribed. A prescription is not guaranteed. If a prescription is issued, it must be filled within one month. The quantity prescribed generally covers one month, in justified cases at most three months.

You can book an appointment at portal.evidena.care/appointments. How the assessment works is described on the How it works page. We answer questions via WhatsApp or at info@evidena.care.

Conclusion

Terpenes are aroma compounds that cannabis produces together with the cannabinoids. The entourage effect is a hypothesis: laboratory studies on effects at the cannabinoid receptors were mostly negative, and in humans there are only individual small studies. There is no evidence for choosing a preparation by terpenes; the decision lies with your doctor.

Frequently asked questions

What are terpenes?

Volatile fragrance and aroma compounds produced by many plants. In cannabis, they are formed in the glandular hairs of the flowers, together with the cannabinoids. Well-known examples are myrcene, limonene, pinene and beta-caryophyllene.

Do terpenes get you high?

The intoxicating effect of cannabis is mainly due to THC. In a controlled study, inhaled limonene alone did not differ from placebo in the effects measured.

Is the entourage effect proven?

No. It is a hypothesis. Several cell studies found no effect of common terpenes at the cannabinoid receptors, another reported the opposite, and there are only a few small controlled studies in humans.

Should I choose a preparation by its terpene profile?

There is no robust evidence in humans for choosing by terpenes. Which preparation can be considered for you is decided by your doctor.

Are terpenes dangerous?

Many terpenes are found in foods and spices. There are few data in humans on the safety of inhaled or highly concentrated terpenes in cannabis products.

Your situation is individual

Discuss your questions with a doctor.

Book a consultation

Sources

  1. Booth JK et al. Terpene synthases from Cannabis sativa. PLoS One. 2017;12(3):e0173911. doi:10.1371/journal.pone.0173911
  2. Booth JK et al. Terpenes in Cannabis sativa - From plant genome to humans. Plant Sci. 2019;284:67-72. doi:10.1016/j.plantsci.2019.03.022
  3. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. doi:10.1111/j.1476-5381.2011.01238.x
  4. Santiago M et al. Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors. Cannabis Cannabinoid Res. 2019;4(3):165-176. doi:10.1089/can.2019.0016
  5. Finlay DB et al. Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors. Front Pharmacol. 2020;11:359. doi:10.3389/fphar.2020.00359
  6. Heblinski M et al. Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels. Cannabis Cannabinoid Res. 2020;5(4):305-317. doi:10.1089/can.2019.0099
  7. LaVigne JE et al. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Sci Rep. 2021;11(1):8232. doi:10.1038/s41598-021-87740-8
  8. Spindle TR et al. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis. Drug Alcohol Depend. 2024;257:111267. doi:10.1016/j.drugalcdep.2024.111267
  9. Elder HJ et al. A Critical Review of the Interactions Between Δ9-THC and Other Naturally Occurring Phytochemical Constituents of Cannabis sativa. Curr Neuropharmacol. 2026, online ahead of print. doi:10.2174/011570159X453562260805073318
  10. Behandlungsempfehlungen für den Einsatz von Cannabisarzneimitteln, Bundesamt für Gesundheit BAG, 17. Januar 2025 (accessed 13 November 2026)

Written by evidena.care editorial team · Published 13 November 2026 · Reviewed 13 November 2026

This article is general information and does not replace medical advice. Whether cannabis therapy is an option for you is decided by a doctor in a personal consultation.